Proactive Investors - Run By Investors For Investors

Buds & Duds: Cannabis stocks perk up; CannTrust shares soar on strong 1Q earnings results

Also on the move were Valens, Aurora, MariMed and The Supreme Cannabis Company
CannTrust reported first-quarter earnings that beat analyst estimates amid higher production and distribution of its medical and recreational cannabis products

Cannabis stocks perked up Tuesday after steep declines yesterday, as stocks rebounded across North American markets.

The North American Marijuana Index, which tracks the top cannabis stocks in the US and Canada, was up 2.2% to 275.1 points by Tuesday midday. The Horizons Marijuana Life Sciences Index ETF was up 3.3% at C$20.08.


Shares of CannTrust Holdings Inc (NYSE:TRST) (OTCMKST:CNTTF) soared on Tuesday after the Canadian company reported first-quarter earnings that beat analyst estimates amid higher production and distribution of its medical and recreational cannabis products.

Shares were up 6.1% at C$6.08 in New York, up 6.6% at US$8.19 in Toronto. 

The company reported net income of C$12.8 million (US$9.5 million), or $0.12 a share, compared with C$11.4 million (US$8.5 million), or $0.12 a share, in the year-ago quarter. The consensus estimate called for earnings of $0.05 a share. 

READ: Cannabis grower CannTrust Holdings' 1Q earnings beats Street estimates on higher production, distribution

Other gainers Tuesday included Valens GroWorks (CSE:VGW) (OTCMKTS:VGWCF), which announced yesterday it has added added leading cannabis expert Deepak Anand to its board of directors.

Shares of the firm were up 7.7% at C$4.50 in Toronto, up 7.7% at US$3.34 in New York.

Kelowna, BC-based Valens is a cannabis company that specializes in the research, development, production, and testing of high-quality cannabis extracts and oils.

Also gaining Tuesday included Aurora Cannabis Inc (NYSE:ACB) (TSE:ACB), which was up 4.5% at C$11.32 in Toronto, up 4.5% at US$8.38 in New York in anticipation of its earning results, which are expected after the closing bell. 


MariMed Inc (OTCMKTS:MRMD) shares were on the decline on Tuesday, after it reported first quarter earnings on Monday. The firm reported that revenues grew 69% to C$3.5 million in 1Q compared to C$2.1 million in the same period a year ago. The company trimmed its net losses for the quarter to $23,211, a 99% improvement over the $1.9 million loss for the first quarter of 2018.

Shares dropped 2.9% at US$3.00. 

Oher laggards included The Supreme Cannabis Company Inc (OTCMKTS:SPRWF), which reported its third-quarter financial results. The firm reported a net loss of C$7.1 million in the quarter, up from $3.3 million in the same period a year ago. Revenue, however, jumped, with 3Q net revenue of C$10 million, a 382% increase from the same period a year ago.

Shares dropped 1% at US$1.46. 

“Our  ompany is pleased with the results of our third quarter financials and with the progress made thus far on our strategic priorities for the 2019 calendar year. This quarter saw a marked increase in revenue on both an annual and quarter-over-quarter basis. This revenue growth was driven by an increase in our capacity at the 7ACRES facility, a ramping up of our product packaging capabilities and, we believe, consumer preference for high-quality cannabis,” said CEO Navdeep Dhaliwal. 

Contact Katie Lewis at [email protected]

Join Proactive’s Crypto, Blockchain and Cannabis Telegram group here
View full TRST profile View Profile

CannTrust Holdings Inc Timeline

Related Articles

Sydney Harbour Bridge
January 22 2019
A phase I study in Australia is evaluating a cannabis spray therapeutic in cancer patients.
cannabis tablet
February 28 2019
The company fills a niche in the medicinal cannabis market, as it continues to push forward its suite of precision oral dose products
medical cannabis concept
February 10 2019
AusCann is a fully integrated early-mover pharmaceutical cannabinoid company.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use